Skip to main content
Fax No
+20882080774
Email:
bgyoussif2@gmail.com
MIS Email
bahaa.youssif@pharm.aun.edu.eg
Mobile
01044353895
Office
0020882411883 - 0020882411883
Google Scholar

Ph.D. . in Pharmaceutical Sciences (Pharmaceutical Organic Chemistry) , Faculty of Pharmacy, Assiut University , 2012
M. Sc. In Pharmaceutical Sciences (Pharmaceutical Organic Chemistry) , Faculty of Pharmacy, Assiut University , 2005
B. Sc. In Pharmaceutical Sciences () , Faculty of Pharmacy, Assiut University , 2000


Associate Professor Faculty of Pharmacy, ِِAssiut University , 2017

Lecturer Faculty of Pharmacy, Assiut University , 2012

Assistant Lecturer Faculty of Pharmacy, Assiut University , 2005

Demonstrator Faculty of Pharmacy, Assiut University , 2000
No. Title سنة البحث
57 Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile 2021
58 Structure-based design, synthesis, and biological evaluation of novel piperine–resveratrol hybrids as antiproliferative agents targeting SIRT-2 2021
59 Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV 2021
60 Synthesis, and biological evaluation of new series of pyrrol-2(3H)-one and pyridazin-3(2H)-one derivatives as tubulin polymerization inhibitors 2021
61 Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors 2021
62 Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity 2021
63 Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation 2020
64 Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors 2020

MemberShip